Altium Capital Management LP Lowers Stock Holdings in Astria Therapeutics, Inc. (NASDAQ:ATXS)

Altium Capital Management LP lowered its position in shares of Astria Therapeutics, Inc. (NASDAQ:ATXS – Free Report) by 1.2% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,347,088 shares of the biotechnology company’s stock after selling 15,984 shares during the period. […]

Related Keywords

United States , ,Nasdaq ,Fairmount Funds Management ,Astria Therapeutics Inc ,Driehaus Capital Management ,Vanguard Group Inc ,Vivo Capital ,Exchange Commission ,Altium Capital Management ,Astria Therapeutics ,Free Report ,Capital Management ,Funds Management ,Global Management ,Vanguard Group ,Get Free Report ,Astria Therapeutics Daily ,Nasdaq Atxs ,Atxs ,Medical ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,